Free exam prep

ABPN Neurocritical Care

Delirium & Toxic-Metabolic Encephalopathy in the ICU

Q: A 68-year-old mechanically ventilated female with severe sepsis from pyelonephritis has a RASS of -1 (drowsy, sustains eye contact for more than 10 seconds). When administered the SAVEAHAART vigilance test, she squeezes the examiner's hand on 3 out of 4 letter 'A' presentations, but also squeezes on the letters 'S' and 'R' (total errors: 3). She correctly answers 4 out of 4 questions on disorganized thinking and follows commands. Her nurse documents an acute fluctuating change from her normal alert baseline and notes she has been lying motionless and staring blankly into space without any agitated behavior. Based on the CAM-ICU algorithm, how should her clinical condition be classified?

CAM-ICU positive for delirium, classified as the hypoactive motor subtype. The Confusion Assessment Method for the ICU (CAM-ICU) requires: Feature 1 (Acute change or fluctuating course of mental status) AND Feature 2 (Inattention, defined as >2 errors on the 10-letter auditory vigilance test like SAVEAHAART), PLUS EITHER Feature 3 (Altered level of consciousness, defined as any current RASS score other than 0) OR Feature 4 (Disorganized thinking, defined as >1 error on standard logic questions). In this patient, Feature 1 is present (acute mental status change), Feature 2 is present (3 errors on SAVEAHAART), and Feature 3 is present (current RASS is -1, which is not 0). Because Features 1, 2, and 3 are fulfilled, the patient meets full diagnostic criteria for delirium regardless of her perfect score on Feature 4. Her presentation of psychomotor apathy, decreased spontaneous movement, and quiet withdrawal without restlessness or combativeness identifies this as the hypoactive motor subtype, which is the most prevalent form in the ICU and can be missed without structured screening.

Q: A 72-year-old male with nosocomial pneumonia is treated with cefepime 2 grams IV every 8 hours. On hospital day 4, his serum creatinine rises from 1.1 mg/dL to 3.4 mg/dL, and he becomes progressively stuporous with diffuse multifocal myoclonic jerking of the extremities and facial muscles. Continuous EEG demonstrates generalized periodic discharges (GPDs) at 1.5 Hz with triphasic morphology. What is the primary pathophysiologic mechanism underlying this patient's acute encephalopathy?

Cefepime accumulation crossing an altered blood-brain barrier and exerting concentration-dependent competitive GABA-A receptor antagonism. Cefepime is a fourth-generation cephalosporin with approximately 85% renal clearance and significant penetration across the blood-brain barrier. In the setting of acute kidney injury or chronic renal insufficiency without dose adjustment, cefepime rapidly accumulates in serum and cerebrospinal fluid. At elevated concentrations, cefepime acts as a competitive antagonist at the GABA-A receptor, inhibiting inhibitory neurotransmission in the cerebral cortex and reticular thalamic networks. This produces severe neurotoxicity typically manifesting 2 to 5 days into therapy as encephalopathy, global cognitive suppression, multifocal myoclonus, asterixis, and non-convulsive status epilepticus. Characteristic electroencephalographic findings include generalized periodic discharges (GPDs) or continuous rhythmic delta activity with triphasic morphology. Management requires immediate cessation of cefepime, dose modification, renal replacement therapy (hemodialysis clears up to 70% of cefepime per session), and supportive antiseizure medications if epileptiform discharges persist.

Q: A multidisciplinary neurocritical care quality improvement committee is updating its protocol for preventing and managing delirium in critically ill patients. Based on current clinical practice guidelines and large randomized trials (such as the MIND-USA study), which intervention has the strongest evidence for reducing delirium incidence and duration in the ICU?

Implementation of the ABCDEF bundle emphasizing spontaneous awakening/breathing trials, avoiding benzodiazepines, and early physical mobilization. Clinical practice guidelines (SCCM PADIS guidelines) and extensive clinical trial evidence strongly endorse the multicomponent ABCDEF bundle (Assess/prevent/manage pain, Both SAT and SBT, Choice of sedation avoiding benzodiazepines, Delirium monitoring and management, Early mobility, and Family engagement) as the standard of care for reducing ICU delirium. Systematic implementation of the ABCDEF bundle significantly decreases delirium days, reduces duration of mechanical ventilation, and improves survival. In contrast, the landmark multicenter MIND-USA trial demonstrated that neither typical antipsychotics (haloperidol) nor atypical antipsychotics (ziprasidone) decrease the duration of delirium, shorten ICU stay, or improve mortality compared to placebo. Consequently, routine pharmacologic prophylaxis with antipsychotics is not recommended; antipsychotics are reserved strictly for managing severe, dangerous agitation that threatens patient safety after non-pharmacologic interventions have failed.

Key Takeaways

Delirium in the neuro-ICU is an independent predictor of prolonged mechanical ventilation, accelerated long-term cognitive decline, and increased 1-year mortality, with hypoactive presentations particularly easy to miss.
The Confusion Assessment Method for the ICU (CAM-ICU) requires an acute fluctuating course (Feature 1) and inattention (Feature 2), combined with either an altered level of consciousness (Feature 3) or disorganized thinking (Feature 4).
Cefepime neurotoxicity is a frequent and dangerous cause of encephalopathy, multifocal myoclonus, and non-convulsive status epilepticus in patients with renal impairment due to crossing an altered blood-brain barrier and antagonizing GABA-A receptors.
Routine administration of typical or atypical antipsychotics does not shorten delirium duration, reduce ventilator days, or improve survival; evidence-based management relies on the non-pharmacologic ABCDEF bundle and sleep-wake preservation.
Deliriogenic sedatives—particularly benzodiazepines—must be minimized in favor of targeted light sedation protocols using dexmedetomidine or propofol.

Last updated: October 2026

Delirium & Toxic-Metabolic Encephalopathy in the ICU

Delirium is an acute, fluctuating syndrome characterized by impaired attention, altered consciousness, and disorganized thinking. Occurring in up to 70–80% of ventilated ICU patients, it signifies acute cerebral organ failure. In the neuro-ICU, delirium independently predicts prolonged mechanical ventilation, increased ICU stay, long-term cognitive decline, and doubled 1-year mortality.

Pathophysiology of Delirium and Acute Brain Dysfunction

Delirium arises from intersecting neurochemical and neuroinflammatory cascades:

Cholinergic Deficiency: Depleted central acetylcholine from the nucleus basalis of Meynert degrades cortical attention, sensory gating, and cognitive processing.
Dopaminergic Excess: Elevated central dopamine drives psychomotor agitation, paranoia, delusions, and hallucinations.
GABA and Serotonergic Flux: Dysregulated inhibitory transmission and serotonin alterations disrupt sleep-wake architecture and circadian rhythms.
Neuroinflammation and Microvascular Dysfunction: Systemic cytokines (TNF-alpha, IL-1beta, IL-6) degrade blood-brain barrier ( $BBB$ ) tight junctions. Microglial activation and endothelial injury induce cerebral microvascular thrombosis, astrocytic edema, and diffuse synaptic failure.

Validated Delirium Screening Tools

Clinical impression can miss delirium, especially hypoactive presentations. Use a validated tool at the institution’s specified intervals and assess competing neurologic causes.

Confusion Assessment Method for the ICU (CAM-ICU)

The CAM-ICU is the standard bedside diagnostic instrument. Patients must first be arousable: a Richmond Agitation-Sedation Scale (RASS) score of -4 or -5 indicates coma, rendering the patient unassessable.

Loading diagram...

The CAM-ICU evaluates four sequential features:

Feature 1: Acute Onset or Fluctuating Course: Acute mental status change from baseline or fluctuating consciousness over the prior 24 hours.
Feature 2: Inattention: The clinician reads the 10-letter sequence S-A-V-E-A-H-A-A-R-T at 1-second intervals. The patient squeezes on "A". $>2$ errors indicates positive inattention.
Feature 3: Altered Level of Consciousness: Any current RASS score other than 0 (alert and calm) is positive (e.g., $+1$ to $+4$ , or $-1$ to $-3$ ).
Feature 4: Disorganized Thinking: Evaluated using four simple logic questions (e.g., "Will a stone float on water?") and a two-step command. $>1$ error indicates positive disorganized thinking.

Important

Delirium is confirmed when a patient demonstrates [Feature 1 AND Feature 2] AND [EITHER Feature 3 OR Feature 4].

Intensive Care Delirium Screening Checklist (ICDSC)

The ICDSC is an 8-item observational checklist scored over an 8-to-24-hour nursing shift (assessing consciousness, inattention, disorientation, hallucinations, psychomotor activity, speech/mood, sleep disturbance, and symptom fluctuation). A score of $\ge 4$ confirms delirium; 1 to 3 indicates subsyndromal delirium.

Delirium Motor Subtypes and Prognosis

Motor Subtype	Clinical Features	Frequency	Prognosis & Significance
Hypoactive	Apathy, psychomotor slowing, lethargy, decreased responsiveness	60–70% (Most common)	Frequently missed; is often missed and is associated with adverse outcomes
Hyperactive	Agitation, combativeness, line pulling, emotional lability	5–10% (Least common)	Immediately identified; lower mortality, but high accidental extubation risk
Mixed	Fluctuations between hypoactive apathy and hyperactive agitation	25–35%	Unpredictable course; requires frequent re-evaluation

Common Toxic-Metabolic Encephalopathies

Sepsis-Associated Encephalopathy (SAE): Acute cerebral dysfunction resulting from circulating inflammatory cytokines and microvascular hypoperfusion without CNS infection. Presents with delirium and EEG slowing (generalized theta/delta rhythms or triphasic waves).
Hepatic Encephalopathy (HE): Hyperammonemia impairs astrocytic metabolism. Astrocytic glutamine synthetase converts ammonia into glutamine, drawing fluid osmotically to cause cytotoxic edema. Presents with asterixis, fetor hepaticus, and triphasic waves on EEG. Treated with lactulose (acidifying the colon to trap $NH_4^+$ ) and rifaximin.
Uremic Encephalopathy: Accumulation of guanidino compounds and nitrogenous waste produces encephalopathy with prominent multifocal myoclonus, asterixis, and seizures. Rapidly improves with hemodialysis.
Electrolyte Derangements: Severe hyponatremia causes cerebral edema; rapid overcorrection ( $>8\text{ mEq/L}$ in 24 hours) risks fatal Osmotic Demyelination Syndrome (ODS) (central pontine myelinolysis), causing delayed pseudobulbar palsy, quadriplegia, and locked-in state.

Critical Care Antimicrobial and Sedative Neurotoxicities

Warning

Cefepime Neurotoxicity: In renal failure without aggressive dose adjustment, cefepime accumulates and competitively antagonizes $GABA_A$ receptors. Patients develop encephalopathy, multifocal myoclonus, asterixis, and non-convulsive status epilepticus within 2 to 5 days, accompanied by generalized periodic discharges (GPDs) or triphasic waves. Management requires immediate drug cessation, dose reduction, hemodialysis, and supportive antiseizure therapy.

Fluoroquinolones (Ciprofloxacin, Levofloxacin): Inhibit $GABA_A$ receptors and stimulate NMDA receptors, triggering agitation, hallucinations, and lowering seizure thresholds.
Benzodiazepines: Potent independent deliriogens. Continuous infusions of midazolam or lorazepam significantly increase delirium incidence and must be minimized.

Evidence-Based Management: The ABCDEF Bundle

The multicomponent ABCDEF Bundle represents the evidence-based standard:

A — Assess, Prevent, and Manage Pain: Proactively treat pain with validated behavioral scales (CPOT/BPS) before sedating (analgesia-first approach).
B — Both SAT and SBT: Coordinate daily paired Spontaneous Awakening and Breathing Trials to reduce sedative accumulation and ventilator days.
C — Choice of Sedation: Target light sedation ( $RASS\ 0\text{ to } -1$ ). Avoid benzodiazepines; use dexmedetomidine (selective $\alpha_2$ -agonist providing non-REM-like cooperable sedation without respiratory depression) or propofol.
D — Delirium: Assess, Prevent, and Manage: Screen routinely using CAM-ICU or ICDSC; aggressively reverse systemic triggers.
E — Early Mobility and Exercise: Protocolized physical and occupational therapy supports recovery and may reduce delirium burden; effects vary by study and patient.
F — Family Engagement: Facilitate family presence, reorientation, and familiar sensory cues.

Environmental Optimization and Sleep Hygiene

Preserve circadian rhythm through daytime natural light exposure, nighttime noise reduction ( $<45\text{ dB}$ ), clustering nocturnal care, and returning sensory aids (glasses, hearing aids) promptly.

Pharmacologic Management: The MIND-USA Trial

Note

The multicenter MIND-USA trial showed that neither haloperidol nor ziprasidone reduces delirium duration, mechanical ventilation time, ICU stay, or mortality compared to placebo. Routine antipsychotic prophylaxis is not recommended.

Antipsychotics (haloperidol, olanzapine, quetiapine) are reserved strictly for acute, dangerous agitation threatening patient safety after non-pharmacologic measures fail. Before administration, clinicians must verify baseline $QTc < 500\text{ ms}$ on 12-lead ECG, monitor for torsades de pointes, and watch for neuroleptic malignant syndrome.

Test Your Knowledge

A 68-year-old mechanically ventilated female with severe sepsis from pyelonephritis has a RASS of -1 (drowsy, sustains eye contact for more than 10 seconds). When administered the SAVEAHAART vigilance test, she squeezes the examiner's hand on 3 out of 4 letter 'A' presentations, but also squeezes on the letters 'S' and 'R' (total errors: 3). She correctly answers 4 out of 4 questions on disorganized thinking and follows commands. Her nurse documents an acute fluctuating change from her normal alert baseline and notes she has been lying motionless and staring blankly into space without any agitated behavior. Based on the CAM-ICU algorithm, how should her clinical condition be classified?

CAM-ICU positive for delirium, classified as the hypoactive motor subtype

Delirium negative, because she scored 0 errors on the disorganized thinking assessment

Unassessable for delirium, because a RASS of -1 represents deep sedative stupor

Subsyndromal hyperactive delirium, because inattention was accompanied by agitation

Test Your Knowledge

A 72-year-old male with nosocomial pneumonia is treated with cefepime 2 grams IV every 8 hours. On hospital day 4, his serum creatinine rises from 1.1 mg/dL to 3.4 mg/dL, and he becomes progressively stuporous with diffuse multifocal myoclonic jerking of the extremities and facial muscles. Continuous EEG demonstrates generalized periodic discharges (GPDs) at 1.5 Hz with triphasic morphology. What is the primary pathophysiologic mechanism underlying this patient's acute encephalopathy?

Autoimmune NMDA-receptor antibody production triggered by microbial molecular mimicry

Cefepime accumulation crossing an altered blood-brain barrier and exerting concentration-dependent competitive GABA-A receptor antagonism

Direct neurotoxic destruction of deep cerebellar Purkinje neurons by beta-lactam crystal deposition

Osmotic demyelination of the central pontine tegmentum secondary to acute hypercreatininemia

Test Your Knowledge

A multidisciplinary neurocritical care quality improvement committee is updating its protocol for preventing and managing delirium in critically ill patients. Based on current clinical practice guidelines and large randomized trials (such as the MIND-USA study), which intervention has the strongest evidence for reducing delirium incidence and duration in the ICU?

Routine prophylactic low-dose intravenous haloperidol administered at bedtime to all mechanically ventilated adults

Scheduled continuous midazolam infusions titrated to maintain deep sedation (RASS -4) for the first 72 hours

Implementation of the ABCDEF bundle emphasizing spontaneous awakening/breathing trials, avoiding benzodiazepines, and early physical mobilization

Prophylactic administration of atypical antipsychotics such as quetiapine immediately upon ICU admission

Sections you finish are checked off in the contents.

Up Next

Cerebral Blood Flow, Metabolism & Autoregulation

Chapter 2: Cerebral Physiology & Intracranial Dynamics